Literature DB >> 9766533

Comparison of bax, waf1, and IMP dehydrogenase regulation in response to wild-type p53 expression under normal growth conditions.

Y Liu1, L B Riley, S A Bohn, J A Boice, P B Stadler, J L Sherley.   

Abstract

Recently, we demonstrated that downregulation of inosine-5'-monophosphate dehydrogenase (IMPD; IMP:NAD oxidoreductase, EC 1.2.1.14), the rate-limiting enzyme for guanine nucleotide biosynthesis, is required for p53-dependent growth suppression. These studies were performed with cell lines derived from immortal, nontumorigenic fibroblasts that express wild-type p53 conditionally by virtue of a metal-responsive promoter. Here, the p53-dependent properties of the original "p53-inducible" fibroblasts are presented in detail and compared to related properties of epithelial cells that also express wild-type p53 conditionally, but by virtue of a temperature-responsive promoter. Both types of p53-inducible cells were designed to approximate normal physiologic relationships between the host cell and the regulated p53 protein. Together, they were used to investigate expression relationships between IMPD and other p53-responsive genes proposed as mediators of p53-dependent growth suppression. In both types of cells, IMPD activity, protein, and mRNA were consistently coordinately reduced in response to p53 expression. In contrast, mRNAs for waf1, bax, and mdm2 showed disparate patterns of expression, being induced in one conditional cell type, but not the other. This distinction in regulation pattern suggests that under normal growth conditions, unlike IMPD downregulation, bax and waf1 induction is not a rate-determining event for p53-dependent growth suppression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9766533     DOI: 10.1002/(SICI)1097-4652(199811)177:2<364::AID-JCP18>3.0.CO;2-9

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

1.  Sparse feature selection identifies H2A.Z as a novel, pattern-specific biomarker for asymmetrically self-renewing distributed stem cells.

Authors:  Yang Hoon Huh; Minsoo Noh; Frank R Burden; Jennifer C Chen; David A Winkler; James L Sherley
Journal:  Stem Cell Res       Date:  2015-01-06       Impact factor: 2.020

2.  A resource for discovering specific and universal biomarkers for distributed stem cells.

Authors:  Minsoo Noh; Janet L Smith; Yang Hoon Huh; James L Sherley
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

3.  CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells.

Authors:  Rouzbeh Taghizadeh; Minsoo Noh; Yang Hoon Huh; Emilio Ciusani; Luca Sigalotti; Michele Maio; Beatrice Arosio; Maria R Nicotra; PierGiorgio Natali; James L Sherley; Caterina A M La Porta
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

4.  Cellular Senescence: Ex Vivo p53-Dependent Asymmetric Cell Kinetics.

Authors:  Lakshmi Rambhatla; Shirley A. Bohn; Patrizia B. Stadler; Jonathan T. Boyd; Ronald A. Coss; James L. Sherley
Journal:  J Biomed Biotechnol       Date:  2001

5.  Ex vivo Expansion of Human Adult Pancreatic Cells with Properties of Distributed Stem Cells by Suppression of Asymmetric Cell Kinetics.

Authors:  Jf Paré; Jl Sherley
Journal:  J Stem Cell Res Ther       Date:  2013-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.